Valeant Scores Afexa for $76M; NuPathe Sinks as FDA Rejects Patch - Aug. 30, 2011

Having trouble viewing this email? View in Browser.

Tuesday, August 30, 2011  |   |   |   |  Gibco® Cell Culture The Difference Between Breakthrough and Try Again Your research will only be as accurate and efficient as yourcell culture. That's why groundbreaking researchers settle for nothing less than Gibco®. It could be the difference between publishing your results and reading someone else's. See all the Gibco® offers for mammalian cell culture or select from various products via this link.   •  Valeant Pharmaceuticals International (VRX) Scores Afexa Life Sciences Inc. for $76 Million; Beats Paladin Labs Inc. (CC:PLB) to the Punch More... •   NuPathe Inc. (PATH) Sinks as FDA Rejects Patch; Stock Falls -1.59 (39.24%) @ 10:18AM EDT More... •  Astellas Pharma Inc. (YPH.BE) Clot Drug Raises Bleeding in Heart Study More... •  Job Cuts Continue at Contract Pharmaceuticals Limited (CPL), Another 128 Employees Unemployed More... •  Fareva to Acquire Pfizer Inc. (PFE) Plant in Henrico County, Add 90 Jobs More... •  AEterna Zentaris (AEZS) Announces Favorable Top-Line Results of Completed Phase 3 Study on AEZS-130 as First Oral Diagnostic Test for Adult Growth Hormone Deficiency More... •  AstraZeneca PLC (AZN) Bloodthinner Shows Mortality Benefit Versus Sanofi (France) (SASY.PA)'s Plavix More... •  Drugmaker GlaxoSmithKline (GSK) Creates "Dragon" Culture; Big Pharma Forces Scientists to Justify Why They Should Keep Being Funded More... More Top News IBC's BioProcess International Conference & Exhibition October 31 - November 4, 2011 - Long Beach, California Event Website Download the 2011 BioProcess International brochure and see why this is YOUR must attend event for 2011. Download your PDF here. BioProcess International is your one stop industry resource for driving down costs, improving quality, achieving rapid, robust and resilient process development and manufacturing. This conference is where challenges are explored, solutions are uncovered and opportunities are developed, making it the largest and most highly respected event solely dedicated to biopharmaceutical manufacturing. Register here today or call 800-390-4078. •  U.S. Researchers Broke Rules In Guatemala Syphilis Study More... •  Bad Sleep Ups Blood Pressure Risk, Brigham and Women's Hospital and Harvard Medical School Study More... •  Dumping Friends on Facebook Helps Make You Secure, Arizona State University Study More... •  Foods Rich in Protein, Dairy Products Help Dieters Preserve Muscle and Lose Belly Fat, McMaster University Study More... •  Bilingual Babies' Vocabulary Linked to Early Brain Differentiation, University of Washington Study More... •  Panda Poop May Be a Treasure Trove of Microbes for Making Biofuels, Mississippi State University Study More... •  New Breast Cancer Gene May Help Predict Risk, Pomeranian Medical University Reveals More... •  Risk-based Centralised Trial Monitoring Wanted by FDA More...   More Featured News SafeBridge Consultants, Inc. announces two Potent Compound Safety Training offerings (may be taken separately or consecutively) The SafeBridge original Potent Compound Safety "Boot Camp"® (Boot Camp I) is a comprehensive two-day course in pharmaceutical potent compound safety focused on training EH&S and related professionals in critical technical concepts and proactive safety programs in pharmaceutical industrial hygiene, occupational and environmental toxicology, analytical chemistry, and risk communication. The SafeBridge Advanced Concepts to Support Drug Development of Potent Compounds from R&D through Manufacturing (Boot Camp II) is a one-day advanced course focused on case studies and problem-solving to address potent compound safety issues in discovery, development, contract manufacturing and commercialization. COURSE SEATING IS LIMITED AND USUALLY SELLS OUT! New Brunswick, New Jersey Boot Camp I September 20 - 21, 2011 Boot Camp II September 22, 2011 Contact: Susan Custer at susan.custer@safebridge.com or 650-961-4820 x 231 orwww.safebridge.com. Advancing Molecular Diagnostics to Personalize Cancer Therapy • Identify key innovations in molecular diagnostics for oncology that may compete with those in development at your company. • Understand the regulatory challenges facing the developers of molecular diagnostics for cancer. • Understand the challenges that surround successfully commercializing a combined drug-diagnostic product and learn how to overcome them. • Discover and analyze the key technology platforms being used in the development of novel molecular diagnostics. Click Here for More Information Nature Methods Nature Methods provides techniques for life scientists and chemists. It is a print and online publication dedicated to publishing novel methods together with significant advances to tried and tested techniques allowing researchers to perform faster, better and more efficient experimental research. Request Now! • Pharm Country (Rochester, New York) Vaccinex, Inc. Director, Clinical Development Responsible for providing clinical direction, clinical operations management, and clinical safety review for the companys ongoing clinical trials in oncology and multiple sclerosis, as well as providing advanced leadership in the clinical aspects of drug development and protocol design for these indications. • Bio NC (Research Triangle Park, North Carolina) Advanced Liquid Logic Scientist/Enzymologist Responsible for planning, designing and running experiments for the purpose of assay development and translation for the purpose sample preparation development and translation. The primary focus is to assist with the transition of research results to useful and manufacturable products, developing core Biochemistry competencies and translating to the digital microfluidic platform. • Genetown (Cambridge, Massachusetts) Acceleron Pharma Associate Director/Director Quality Assurance Manage the systems and procedures that ensure compliance with ICH guidelines and FDA/EMEA applicable regulations (cGLP, cGMP, cGCP). Ensure that company procedures are consistent with clinical and development activities. • BioCapital (Frederick, Maryland) SAIC-Frederick, Inc. Research Associate III Responsible for contacting and interacting with equipment representatives; negotiating costs for equipment and determining the best options for purchases; establishing space for microscopy set-up; initializing stock; arranging laboratory space; training new post-docs in cell biology and microscopy techniques; maintaining tissue culture cell lines; participating in biochemical/mass spec studies aimed at characterizing centrosome components; preparing manuscripts and presenting results at meetings. • BioForest (Eugene, Oregon) Life Technologies Scientist III, Production Responsible for technical troubleshooting of products and manufacturing processes, for the development and transfer of new products, and for initiating process improvements in organic chemistry production at the Eugene site. Get Noticed! Add your resume to the BioSpace Career Center! See more than 5,000 job postings in the BioSpace Career Center! Biotech Beach Career Fair Job seekers can spend a day with HR representatives and Hiring Managers from top biotech, pharma, medical device and diagnostics companies in the Southern California region. Candidates with a 4-year degree in the life sciences and a minimum of 2-years of industry related experience are invited to attend. (Equivalent work experience may be considered in lieu of a four-year college degree. PhD and Postdoc candidates welcome.) Exhibiting companies are recruiting for positions in areas such as: QA/QC, clinical research, engineering, manufacturing, biostatistics, clinical data management, chemistry, regulatory affairs, and research. Job seekers may register here. • Biotech Beach Career Fair, San Diego, CA September 22, 2011 • BioMidwest Career Fair, Chicago, IL October 4, 2011 • Pharm Country Career Fair, Bridgewater, NJ October 5, 2011 • Biotech Bay Career Fair, Burlingame, CA October 11, 2011 • Bio NC Career Fair, Durham, NC October 20, 2011 • BioCapital Beach Career Fair, Bethesda, MD November 1, 2011 • Genetown Career Fair, Cambridge, MA November 7, 2011 More information about BioSpace's Career Fairs BioSpace White Paper Biotech Career Fairs For Job Seekers 101: Control Your Experience By June Salvati, BioSpace Director of Events and Corporate Services Operon Biotechnologies, Inc. 2211 Seminole Drive Huntsville, Alabama 35805 U.S.A. Phone: 800-688-2248 Operon Biotechnologies, Inc. is the global market leader in high throughout synthesis and provider of a wide range of quality DNA oligonucleotides, array-ready oligo sets (AROS™) and preprinted slides (OpARRAY™). Driven by incomparable customer service and reliable delivery, Operon employs advanced synthesis technologies and support. More Company Profiles FREE Subscription to Applied Clinical Trials Applied Clinical Trials provides a forum where pharmaceutical product developers can communicate with the medical researchers who test their new products. It strives to be the resource of first resort and a thought leader for the global community of pharmaceutical and medical professionals who design, initiate, manage, conduct, and monitor clinical trials in the tightly regulated, highly competitive pharmaceutical industry. Post Your: News | Jobs | Company Profile | Event | Advertising / Sponsorship BioSpace Inc. 6465 South Greenwood Plaza, Suite 400 Centennial, Colorado 80111 U.S.A. Phone: 877-277-7585 Fax: 800-595-2929 BioSpace Inc. 90 New Montgomery Street, Suite 414 San Francisco, California 94105 U.S.A. Phone: 877-277-7585 Fax: 415-576-9217 Send questions and comments to the BioSpace News Beat Team. Editor & Publisher: Rosemary Do Editorial & Production Staff: Lana Ho, Suvarna Sheth, Maysa Darwish, Tammy Liu BioSpace.com - Life. Science. Community. • BioSpace is a registered trademark of BioSpace, Inc. • Please distribute this e-cast freely. • Credit any excerpts as follows: Copyright 2011 BioSpace http://www.biospace.com • While BioSpace and its agents used their best efforts in collecting and preparing the information published herein, we do not assume, and hereby disclaim, any liability for any loss or damage caused by errors or omissions, whether such errors or omissions resulted from negligence, accident or other causes. If someone forwarded this news to you and you'd like to receive your own copy FREE of charge, simply Subscribe here. Safely unsubscribe from Biospace.com e-mail at any time by managing your account here.